v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 1,256 2,430 3,762 3,660
Sales and marketing 474 34 560 137
Depreciation and amortization 87 73 229 146
General and administrative 1,852 1,764 5,531 5,720
Total operating expenses 3,669 4,301 10,082 9,663
Loss from operations (3,669) (4,301) (10,082) (9,663)
Other income (expense):        
Interest expense 0 0 0 (823)
Interest income 76 6 82 9
Total other income (expense) 76 6 82 (814)
Net loss (3,593) (4,295) (10,000) (10,477)
Dividend to Series A and B preferred stockholders 0 0 0 (160)
Net loss attributable to common stockholders $ (3,593) $ (4,295) $ (10,000) $ (10,637)
Net loss per common share, basic and diluted (in dollars per share) $ (0.17) $ (0.27) $ (0.55) $ (0.83)
Weighted average number of common shares outstanding, basic and diluted (in shares) 21,062,444 15,994,002 18,244,330 12,877,047

Source